Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000950170-24-084940
Filing Date
2024-07-19
Accepted
2024-07-19 16:30:03
Documents
2
Period of Report
2024-07-16

Document Format Files

Seq Description Document Type Size
1 3 ownership.html 3  
1 3 ownership.xml 3 1581
2 EX-24.1 nams-ex24_1.htm EX-24.1 17574
  Complete submission text file 0000950170-24-084940.txt   20640
Mailing Address 400 SOMERSET CORPORATE BOULEVARD BRIDGEWATER NJ 08807
Business Address
McKenna Mark C. (Reporting) CIK: 0001749623 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-41562 | Film No.: 241128109

Mailing Address GOOIMEER 2-35 NARRDEN P7 1411 DC
Business Address GOOIMEER 2-35 NARRDEN P7 1411 DC 35 206 2971
NewAmsterdam Pharma Co N.V. (Issuer) CIK: 0001936258 (see all company filings)

EIN.: 000000000 | State of Incorp.: P7 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)